RADNOR, Pa., June 07, 2021 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP reminds Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) investors that the firm has filed a securities fraud class action lawsuit in the United States District Court for the District of Maryland against Emergent on behalf of those who purchased or acquired Emergent common stock between April 24, 2020 and April 16, 2021, inclusive (the “Class Period”). This action, captioned Roth v. Emergent BioSolutions Inc., et al., Case No. 1:21-cv-01189-PX (the “Roth Action”), was filed in the United States District Court for the District of Maryland (Southern Division). To view a copy of the Roth Action complaint, please click here.

By A Silva